Skip to main content

Vyome Holdings, Inc

HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001427570

No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Vyome Holdings, Inc changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of HIND: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders1518+3
Shares435.2K266.5K−168.7K (−38.8%)
Value$108.3K$49.1K−$59.2K (−54.7%)

New holders (6)

Institutions that held Vyome Holdings, Inc at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to HIND in Q1 2024
InstitutionSharesValue% of portfolio
Goldman Sachs Group Inc23,036$4.25K0.00%
Jane Street Group, LLC22,926$4.23K0.00%
XTX Topco Ltd12,296$2.27K0.00%
Cornerstone Planning Group LLC135$230.00%
JPMorgan Chase & Co1$00.00%
CIBC Private Wealth Group, LLC1$00.00%

Sold out (3)

Institutions that held Vyome Holdings, Inc at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of HIND in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Citadel Advisors LLC72,866$18.2K
Virtu Financial LLC73,532$18.0K
Susquehanna International Group, LLP59,038$14.7K